Ribavirin treatment of acute and chronic hepatitis E: A single-centre experience

Liver International

Volumn 33, Issue 5, 2013, Pages 722-726

  Pischke, Sven ^a   Hardtke, Svenja ^a   Bode, Ulrike ^a   Birkner, Stephan ^b   Chatzikyrkou, Christos ^a   Kauffmann, Wolfgang ^c   Bara, Christoph L ^a   Gottlieb, Jens ^a   Wenzel, Juergen ^d   Manns, Michael P ^a   Wedemeyer, Heiner ^a   Beutel, G ^a   Cieplik, N ^a   Lehner, F ^a   Raupach, R ^a   Darnedde, M ^a   Bremer, B ^a   Malek, N ^a,e   Haverich, A ^a   Gwinner, W ^a   Cornberg, M ^a   Jilg, W ^d   more..

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Praxis Dr Birkner   (Germany)

^c Vivantes Klinikum   (Germany)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Acute liver failure; Hepatitis E; HEV; Ribavirin; Transplantation; Treatment

Indexed keywords

HEMOGLOBIN; RIBAVIRIN;

ADULT; AGED; ANEMIA; ANTIVIRAL THERAPY; ARTICLE; ASYMPTOMATIC INFECTION; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENOTYPE; HEART ATRIUM FIBRILLATION; HEPATITIS E; HUMAN; IMMUNE DEFICIENCY; LIVER FUNCTION; MALE; PROSPECTIVE STUDY; TREATMENT RESPONSE; VIRAL CLEARANCE; VIREMIA;

ADULT; COHORT STUDIES; FEMALE; GERMANY; HEMOGLOBINS; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RIBAVIRIN; RNA, VIRAL; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 84876093975     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12114     Document Type: Article

References (18)

1. Wedemeyer H, Pischke S, Manns MP. Pathogenesis and Treatment of Hepatitis E Virus Infection. Gastroenterology 2012; 142: 1388-97, e1381.
2. Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet 2012; 379: 2477-88.
3. Pischke S, Wedemeyer H. Hepatitis E virus infection: multiple faces of an underestimated problem. J Hepatol 2012, in press. doi: 10.1016/j.jhep.2012.12.013.
4. Rein DB, Stevens G, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 2012; 55: 988-97.
5. Acharya SK, Panda SK. Hepatitis E: water, water everywhere - now a global disease. J Hepatol 2011; 54: 9-11.
6. Peron JM, Dalton H, Izopet J, et al. Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin? J Hepatol 2011; 54: 1323-4; author reply 1324-1325.
7. Gerolami R, Borentain P, Raissouni F, et al. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol 2011; 52: 60-2.
8. Goyal R, Kumar A, Panda SK, Paul SB, Acharya SK. Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report. Antivir Ther 2012; 17: 1091-6.
9. Suneetha PV, Pischke S, Schlaphoff V, et al. Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection. Hepatology 2012; 55: 695-708.
10. Kamar N, Abravanel F, Selves J, et al. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation 2011; 89: 353-60.
11. Haagsma E, Riezebos-Brilman A, Van den Berg AP, Porte RJ, Niesters HG. Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transpl 2010; 16: 474-7.
12. Kamar N, Rostaing L, Abravanel F, et al. Pegylated Interferon-alpha for Treating Chronic Hepatitis E Virus Infection after Liver Transplantation. Clin Infect Dis 2010; 50: e30-3.
13. Mallet V, Nicand E, Sultanik P, et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 2010; 153: 85-9.
14. Kamar N, Rostaing L, Abravanel F, et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology 2010; 139: 1612-8.
15. Pischke S, Suneetha PV, Baechlein C, et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl 2010; 16: 74-82.
16. Pischke S, Stiefel P, Franz B, et al. Chronic hepatitis E in heart transplant recipients. Am J Transplant 2012; 12: 3128-33.
17. Mederacke I, Bremer B, Heidrich B, et al. Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics. J Clin Microbiol 2010; 48: 2022-9.
18. European Association for the Study of the Liver. 2011. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol; 55: 245-64.